<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Full-length Dysferlin Transfer by the Hyperactive Sleeping Beauty Transposase Restores Dysferlin-deficient Muscle</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-01-19">19 January 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Zsuzsanna</forename><surname>Izsvák</surname></persName>
							<email>zizsvak@mdc-berlin.de</email>
							<affiliation key="aff0">
								<orgName type="department">Max Delbrück Center for Molecular Medicine of the Helmholtz Society</orgName>
								<orgName type="institution">Mobile DNA</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><surname>Marg</surname></persName>
							<email>andreas.marg@charite.de</email>
							<affiliation key="aff1">
								<orgName type="department">Max Delbrück Center for Molecular Medicine</orgName>
								<orgName type="laboratory">Muscle Research Unit, Experimental and Clinical Research Center (ECRC), a joint cooperation between the Charité</orgName>
								<orgName type="institution">Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Helena</forename><surname>Escobar</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Max Delbrück Center for Molecular Medicine of the Helmholtz Society</orgName>
								<orgName type="institution">Mobile DNA</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Verena</forename><surname>Schöwel</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Max Delbrück Center for Molecular Medicine</orgName>
								<orgName type="laboratory">Muscle Research Unit, Experimental and Clinical Research Center (ECRC), a joint cooperation between the Charité</orgName>
								<orgName type="institution">Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Simone</forename><surname>Spuler</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Max Delbrück Center for Molecular Medicine</orgName>
								<orgName type="laboratory">Muscle Research Unit, Experimental and Clinical Research Center (ECRC), a joint cooperation between the Charité</orgName>
								<orgName type="institution">Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department">Max Delbrück Center for Molecular Medicine</orgName>
								<address>
									<addrLine>Robert-Rössle Str. 10</addrLine>
									<postCode>13125</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="laboratory">Muscle Research Unit</orgName>
								<orgName type="institution">ECRC</orgName>
								<address>
									<addrLine>Lindenberger Weg 80</addrLine>
									<postCode>13125</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Full-length Dysferlin Transfer by the Hyperactive Sleeping Beauty Transposase Restores Dysferlin-deficient Muscle</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-01-19">19 January 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">73B9659BA4DBD5BC859ACD58DE3148B5</idno>
					<idno type="DOI">10.1038/mtna.2015.52</idno>
					<note type="submission">Received 13 November 2015; accepted 13 November 2015; advance online publication 19 January 2016.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:30+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Gene inseretion deletion or modification dysferlin</term>
					<term>gene therapy</term>
					<term>myoblast transplantation</term>
					<term>Sleeping Beauty transposon</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Dysferlin-deficient muscular dystrophy is a progressive disease characterized by muscle weakness and wasting for which there is no treatment.</s><s>It is caused by mutations in DYSF, a large, multiexonic gene that forms a coding sequence of 6.2 kb.</s><s>Sleeping Beauty (SB) transposon is a nonviral gene transfer vector, already used in clinical trials.</s><s>The hyperactive SB system consists of a transposon DNA sequence and a transposase protein, SB100X, that can integrate DNA over 10 kb into the target genome.</s><s>We constructed an SB transposon-based vector to deliver full-length human DYSF cDNA into dysferlin-deficient H2K A/J myoblasts.</s><s>We demonstrate proper dysferlin expression as well as highly efficient engraftment (&gt;1,100 donor-derived fibers) of the engineered myoblasts in the skeletal muscle of dysferlin-and immunodeficient B6.Cg-Dysf prmd Prkdc scid /J (Scid/BLA/J) mice.</s><s>Nonviral gene delivery of full-length human dysferlin into muscle cells, along with a successful and efficient transplantation into skeletal muscle are important advances towards successful gene therapy of dysferlin-deficient muscular dystrophy.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>2]<ref type="bibr" target="#b2">[3]</ref> They are encompassed by the term dysferlinopathy and affect the proximal and/or distal muscles of the limbs.</s><s>2]<ref type="bibr" target="#b2">[3]</ref> Patients usually become wheelchair-bound within 10-20 years of disease onset due to progressive muscle degeneration, weakness, and atrophy.</s></p><p><s>DYSF spans over 150 kb of genomic DNA in chromosome 2p13 and comprises 55 exons that form a coding sequence of 6.2 kb. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b3">4</ref></s><s>The 237 kDa dysferlin protein belongs to the ferlin family, a group of large proteins with important roles in vesicle trafficking and fusion. <ref type="bibr" target="#b4">5</ref></s><s>DYSF is expressed in several tissues, including kidney and immune cells, but its highest expression was reported in muscle, <ref type="bibr" target="#b5">6</ref> where dysferlin is mainly detected in mature myofibers. <ref type="bibr" target="#b6">7</ref></s><s>In muscle fibers, dysferlin localizes predominantly to the sarcolemma, but it is also present at the transverse tubules. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b8">9</ref></s><s>Dysferlin has a well-studied role in membrane repair, an important process in muscle fibers, which are continually subject to mechanical stress-induced injuries.</s><s>Mutations in DYSF have been exclusively associated with skeletal muscle diseases.</s><s>Absence of dysferlin leads to impaired resealing of sarcolemmal wounds. <ref type="bibr" target="#b9">10</ref></s><s>Defects in dysferlin are also known to cause increased inflammatory attack to muscle fibers, which contributes to the exacerbation of the muscle pathology. <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b11">12</ref></s><s>rrently, there is no treatment for dysferlinopathy.</s><s>Given that a single gene is causative for the pathology, gene therapy holds great promise.</s><s>However, the large size of the DYSF coding sequence represents a challenge for gene transfer approaches, since most viral vectors used in gene therapy have a lower cargo capacity.</s><s>Sleeping Beauty (SB) transposon is a nonviral genetic tool widely used for stable gene transfer in various cell types. <ref type="bibr" target="#b12">13</ref></s><s>This plasmid-based, bi-component system consists of a transposon DNA sequence and a transposase protein that excises the transposon from the donor plasmid and integrates it into the target genome.</s><s>The transposon can be engineered to carry any gene of interest.</s><s>Although the efficacy of transposase-mediated transgene insertion decreases with increasing cargo size, <ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b14">15</ref> the hyperactive SB100X transposase is still capable of integrating large, over 10 kb or even BAC-size DNA. <ref type="bibr" target="#b15">16</ref></s><s>Thus, the SB system is well suited to deliver large sequences, such as the DYSF coding sequence.</s><s>Most importantly, the SB system has already been used in a clinical setup. <ref type="bibr" target="#b16">17</ref></s><s>We constructed an SB transposon-based vector to deliver the full-length human DYSF cDNA into dysferlin-deficient H2K myoblasts (H2K A/J). <ref type="bibr" target="#b17">18</ref></s><s>H2K myoblasts are conditionally immortalized through expression of the tsA58 thermosensitive SV40 large-T-antigen driven by the H-2K b promoter. <ref type="bibr" target="#b18">19</ref></s><s>They have extensive proliferative capacity in vitro and can engraft robustly into muscle, offering a proper model to test the feasibility of our therapeutic strategy consisting of stably expressing fulllength DYSF using the SB system. <ref type="bibr" target="#b18">19</ref></s><s>H2K A/J myoblasts are derived from dysferlin-null mice, harboring a homozygous Dysf prmd mutation <ref type="bibr" target="#b19">20</ref> and the H-2K b tsA58 allele. <ref type="bibr" target="#b20">21</ref></s><s>Our strategy involved the optimization of a pretransplantation treatment by combining irradiation and cardiotoxin (CTX) injection.</s><s>Our results demonstrate proper dysferlin reconstitution as well as highly efficient engraftment of engineered myoblasts in dysferlin-and immunodeficient B6.Cg-Dysf prmd Prkdc scid /J (Scid/ BLA/J) mice. <ref type="bibr" target="#b21">22</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>H2K A/J muscle cells properly express full-length human DYSF following SB-mediated gene transfer</head><p><s>To ensure optimal expression of the therapeutic gene, we chose the synthetic c5-12 (Spc5-12) promoter. <ref type="bibr" target="#b22">23</ref></s><s>The Spc5-12 promoter was constructed by random assembly of evolutionarily conserved transcription factor binding sites, providing tissue specificity in adult skeletal muscle.</s><s>Importantly, the Spc5-12 promoter was shown to drive strong transgene expression in vitro in myoblasts and myotubes <ref type="bibr" target="#b22">23</ref> and in vivo in mouse myofibers. <ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b24">25</ref></s><s>The size of the Spc5-12 promoter is &lt;400 bp.</s><s>In our hands, a duplicate of Spc5-12 (2xSpc5-12) regulatory sequence proved to be the most efficient in driving transgene expression in H2K A/J myoblasts.</s><s>We generated a bicistronic vector, in which the full-length human DYSF cDNA was followed by a GFP reporter.</s><s>GFP was preceded by an Internal Ribosome Entry Site (IRES) sequence to allow simultaneous translation of both cistrons (pT2-2xSpc5-12-hDYSF-IRES-GFP; short: hDYSF-IRES-GFP) (Figure <ref type="figure" target="#fig_0">1a</ref>). 2 × 10 6 H2K A/J myoblasts were electroporated with 2 µg of hDYSF-IRES-GFP and 200 ng of an expression vector for SB100X transposase. <ref type="bibr" target="#b14">15</ref></s><s>The engineered cells were selected by FACS sorting for the GFP signal after 11 days.</s><s>At this time, the background GFP + signal deriving from nonintegrated plasmid DNA could no longer be detected (Supplementary Figure <ref type="figure" target="#fig_0">S1</ref>).</s><s>Due to the rather low transfection rate of the large therapeutic plasmid (2-3%), we enriched the culture for GFP + cells through three rounds of cell sorting to obtain a population of 98.6% positive cells (Figure <ref type="figure" target="#fig_0">1b</ref>).</s></p><p><s>Next, we analyzed FACS-sorted, GFP + H2K A/J myoblasts and differentiated myotubes for dysferlin expression by western blot and immunohistochemistry (Figure <ref type="figure" target="#fig_0">1c,d</ref>).</s><s>Dysferlin was detected in low amounts in engineered H2K A/J myoblasts, but its expression level increased with differentiation (Figure <ref type="figure" target="#fig_0">1c</ref>).</s><s>H2K A/J cells not engineered or engineered with an SB-based vector encoding only a GFP reporter (pT2-CAG-IRES-GFP) did not express dysferlin (Figure <ref type="figure" target="#fig_0">1c</ref>).</s><s>Dysferlin-immunofluorescence revealed strong membrane staining in engineered myotubes (Figure <ref type="figure" target="#fig_0">1d</ref>).</s><s>These experiments indicate that dysferlin expression in corrected H2K A/J cells (H2K A/J-DYSF + ) follows the physiological time and spatial distribution.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Corrected H2K A/J myoblasts can efficiently be transplanted into Scid/BLA/J mouse muscle</head><p><s>We next asked whether corrected and FACS-sorted H2K A/J myoblasts would be capable of reconstituting dysferlin in vivo following transplantation into the tibialis anterior (TA) muscle of Scid/BLA/J mice.</s><s>The abrogation of the regenerative capacity of the host muscle by irradiation has been shown to enhance the engraftment of donor cells. <ref type="bibr" target="#b25">26</ref></s><s>We used a recently developed method for highly precise focal irradiation of mouse hind limbs using an image guided radiosurgery robot <ref type="bibr" target="#b26">27</ref> and transplanted 3 × 10 5 H2K A/J-DYSF + myoblasts into 18 Gy irradiated TA muscles of Scid/BLA/J mice. <ref type="bibr" target="#b21">22</ref></s><s>Using immunohistochemistry, we detected up to 140 dysferlin-positive fibers in muscles collected 3 (n = 2) and 6 weeks (n = 2) posttransplantation (Figure <ref type="figure" target="#fig_2">2a</ref>,b, left columns).</s><s>These data suggest that the donor myoblasts engrafted successfully and gave rise to dysferlin expressing myofibers in the host muscle.</s><s>Next, we stimulated regeneration in the host muscles using CTX, a strategy reported to improve engraftment of donor myoblasts. <ref type="bibr" target="#b27">28</ref></s><s>CTX causes myofiber degeneration and necrosis, resulting in acute damage-induced muscle regeneration, but it does not damage satellite cells. <ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b28">29</ref></s><s>In order to induce a regenerative environment, we treated the TA muscles of Scid/BLA/J mice with CTX at the same time point at which 3 × 10 5 H2K A/J-DYSF + myoblasts were injected.</s><s>This injury model resulted in a dramatic increase in dysferlin-positive fibers in the transplanted TA muscles (Figure <ref type="figure" target="#fig_2">2a</ref>,b, middle and right columns).</s><s>We counted 500-1,100 dysferlin-positive muscle fibers/cross-sectional area, extending a length of at least 5 mm, 3 weeks posttransplantation (n = 2) (Figure <ref type="figure" target="#fig_2">2a</ref>, middle and right columns).</s><s>We still detected 400-1,000 dysferlin expressing fibers/cross sectional area in muscles collected 6 weeks posttransplantation (n = 2) (Figure <ref type="figure" target="#fig_2">2b</ref>, middle and right columns).</s><s>Per section, the area of the transplant extended up to 1,000 × 800 µm.</s><s>As in healthy muscle, dysferlin was mainly expressed at the sarcolemma.</s><s>No dysferlin-positive fibers were detected in the control muscles that were only irradiated or injected with CTX (not shown).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Muscle regeneration using H2K A/J-DYSF + cells appears morphologically normal</head><p><s>We next investigated whether transplants derived from H2K A/J-DYSF + myoblasts would properly regenerate muscle.</s><s>Serial cryosections from transplanted TA muscles were immunostained for dysferlin to identify the transplanted area.</s><s>H&amp;E (Hematoxylin and Eosin), Gomori Trichrome, and NADH-dehydrogenase stains revealed that the grafted area was sharply demarcated towards the host muscle.</s><s>There was only a mild increase in connective tissue mass between host-and graft-derived muscle.</s><s>Grafted muscle displayed all typical features of regeneration, including large variation of fiber size, internalized nuclei in a high percentage of fibers, loose tissue structure, and lack of inflammatory infiltrates (Figure <ref type="figure" target="#fig_4">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>H2K A/J-DYSF + muscle cells gave rise to multiple Pax7positive cells</head><p><s>Myonuclei of mature fibers are postmitotic and the de novo nuclei are provided exclusively by myoblast-myoblast or myoblast-to-myofiber fusion.</s><s>Therefore, only engraftment of a subset of donor-derived cells as satellite cells would ensure contribution to muscle regeneration in pathological circumstances and a long-lasting therapeutic effect. <ref type="bibr" target="#b27">28</ref></s><s>Satellite cells can be identified by their expression of the transcription factor Pax7 <ref type="bibr" target="#b29">30</ref> and their localization beneath the basal lamina of myofibers. <ref type="bibr" target="#b30">31</ref></s><s>We found cells positive for the expression of both Pax7 and dysferlin.</s><s>A few of them located underneath forming basal lamina structures identified by laminin staining, but many of them had not yet adopted a satellite cell position and were interstitial (Figure <ref type="figure" target="#fig_5">4</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Here, we describe a proof of principle of an SB-based gene transfer into mouse myoblasts.</s><s>In the last decades, several approaches have been taken to restore dysferlin function in dysferlinopathies.</s><s>In allogenic cell transplantation studies, dysferlin expression was reconstituted in mouse myofibers by transplanting labeled wild-type mouse myoblasts into SJL mice. <ref type="bibr" target="#b31">32</ref></s><s>In addition, expression of human dysferlin could be detected following intramuscular transplantation of human control myoblasts into SCID mice. <ref type="bibr" target="#b31">32</ref></s><s>In gene therapy studies, adeno-associated viral (AAV) vectors have been extensively investigated for dysferlin gene transfer.</s><s>Due to their limited cargo capacity, AAV vectors cannot deliver the full-length DYSF coding sequence.</s><s>4]<ref type="bibr" target="#b34">[35]</ref> Dual AAV-mediated dysferlin expression has been shown to persist for &gt;1 year in mouse skeletal muscle. <ref type="bibr" target="#b34">35</ref></s><s>However, AAV vectors are non-self-replicating and long-term treatment of patients with skeletal muscle disorders may require repeated vector administrations, with the possible complication of immune responses against the viral capsid. <ref type="bibr" target="#b35">36</ref></s><s>he use of lentiviral vectors has enabled the successful delivery of full-length dysferlin into patient-derived CD133 + cells in vitro, but the results in vivo have so far been discouraging. <ref type="bibr" target="#b36">37</ref></s><s>In addition, there have been attempts to use RNAbased strategies like exon skipping or trans-splicing to treat dysferlinopathies.</s><s>Exon 32 of DYSF might be dispensable for protein function, since a patient harboring a mutation in this exon developed a mild disease phenotype. <ref type="bibr" target="#b37">38</ref></s><s>Successful targeting of exon 32 to induce exon skipping has been shown in vitro using antisense oligonucleotides. <ref type="bibr" target="#b38">39</ref></s><s>Furthermore, our laboratory demonstrated successful spliceosomemediated trans-splicing of the DYSF pre-mRNA both in vitro and in vivo. <ref type="bibr" target="#b39">40</ref></s><s>0]<ref type="bibr" target="#b40">[41]</ref> Our current work using ex vivo delivery of an SB transposon-based therapeutic construct has provided the most efficient results so far, in terms of engraftment and dysferlin protein restoration of any cell  We have transplanted engineered H2K A/J myoblasts into the TA muscles of Scid/BLA/J mice.</s><s>We determined engraftment efficiency based on the presence of donor-derived myofibers, expressing dysferlin.</s><s>We could use dysferlin expression directly to monitor engraftment, as mice carrying a homozygous Dysf prmd allele do not express any dysferlin protein. <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b21">22</ref></s><s>Accordingly, we did not detect any dysferlin-positive fibers in nongrafted muscles of Scid/BLA/J mice that were uninjured, irradiated only, or had just received CTX.</s></p><formula xml:id="formula_0">A / J -G F P − A / J -G F P + A / J -D Y S F + H 2 K w t A / J -G F P − A / J -G F P + A / J -D Y S F + h u . m y o t</formula><p><s>Immortalized C2C12 mouse myoblasts have been shown to rapidly form tumors when transplanted into TA muscles of mdx nu/nu and nondystrophic beige/nu/Xid mice. <ref type="bibr" target="#b41">42</ref></s><s>In those studies, tumor formation was especially evident in muscles that had been irradiated.</s><s>H2K myoblasts are only conditionally immortalized and are not expected to form tumors in vivo.</s><s>Still, spontaneous transformation during in vitro culturing could occur and might result in tumor formation following grafting into an immunosuppressed model.</s><s>Notably, we did not observe any tumors in the grafted muscles or the surrounding tissues at any of the examined time points,  suggesting that that the transplanted pool was free of cells spontaneously transformed in culture.</s></p><p><s>In our hands, a pretransplantation treatment consisting of a combination of irradiation with CTX injection improved engraftment as compared to irradiation alone.</s><s>Although it is accepted that inactivation of the endogenous satellite cells by radiation or cryoinjury is beneficial for the engraftment of donor cells, the role of additional injury using myotoxins is rather controversial. <ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b42">43</ref></s><s>The differences in transplantation efficacy might be partially explained by technical reasons.</s><s>Also, each disease and engraftment model may require a specific pretransplantation treatment that needs to be optimized individually.</s><s>In this regard, it is important to note that muscle regeneration only occurs when Pax7-positive satellite cells, the proper stem cells of skeletal muscle, are present in the tissue. <ref type="bibr" target="#b43">44,</ref><ref type="bibr" target="#b44">45</ref></s><s>In agreement with this assumption, engraftment and contribution to myofibers of nonmuscle stem cell types, like mesoangioblasts or CD133 + cells, have only been demonstrated in nonirradiated muscles of Scid/BLA/J mice, injured with myotoxins only, where the endogenous satellite cells were intact. <ref type="bibr" target="#b36">37,</ref><ref type="bibr" target="#b45">46</ref></s><s>Our results clearly support the positive role of a double injury model.</s><s>Although formation of functional satellite cells by transplanted myoblasts has been reported, <ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b46">47</ref> the detection of multiple Pax7-positive, dysferlin-positive cells in the graft's area was unexpected because engineered H2K A/J myoblasts had been extensively expanded ex vivo prior to transplantation.</s><s>Whether donor-derived satellite cells with true stem cell characteristics were established remains unresolved.</s></p><p><s>Our SB-based approach can theoretically be applied to all loss-of-function mutations in DYSF.</s><s>The effect of SB-mediated DYSF delivery is more difficult to foresee in dysferlinopathies caused by missense mutations in DYSF.</s><s>In these individuals, the residual dysferlin protein might be accumulated, resulting in aggregates within the muscle cell. <ref type="bibr" target="#b47">48</ref></s><s>In these cases, the suitability of this therapeutic approach must first be assessed in vitro, since overexpression of dysferlin might cause a myopathy itself. <ref type="bibr" target="#b48">49</ref></s><s>In principle, SB could be used to deliver genes relevant for other muscular dystrophies as well.</s><s>SB has several advantageous features compared with other integrating vectors, including a potentially safer, close-to-random genomic integration profile versus lentivirus or other transposon-based systems. <ref type="bibr" target="#b49">50,</ref><ref type="bibr" target="#b50">51</ref></s><s>Furthermore, since it is a plasmid-based system, it is simple and inexpensive to manufacture, which represents a substantial benefit for clinical use.</s><s>Maintenance of human primary myoblast cultures, however, is labor intensive and expensive.</s><s>On the other hand, it remains to be established how human muscle needs to be prepared in order to accept autologous myoblast transplants.</s><s>If needed, more gentle or alternative treatments to render patients' muscles receptive to grafts, while avoiding irreversible tissue damage, should be evaluated.</s></p><p><s>Altogether, our results show nonviral integration of fulllength human dysferlin into muscle cells as well as successful, efficient transplantation into skeletal muscle.</s><s>These</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head><p><s>Plasmid vectors.</s><s>The SB100X expression vector was previously described. <ref type="bibr" target="#b14">15</ref></s><s>The SB-based reporter vector pT2-CAG-IRES-GFP was kindly provided by Angélica García Pérez, Max Delbrück Center for Molecular Medicine, Berlin.</s><s>The SB-based vector for full-length dysferlin transfer (hDYSF-IRES-GFP) was constructed as follows: the full-length human dysferlin coding sequence (accession #DQ267935) was extracted from the pDONR221:15803 plasmid (provided by The Jain Foundation) with SpeI + NotI and cloned into an empty SB transposon plasmid <ref type="bibr" target="#b51">52</ref> previously digested with XbaI + NotI (resulting vector -pT2-hDYSF).</s><s>The Spc5-12 promoter sequence was extracted from pAAV-Spc5-12-huDysco (Kindly provided by George Dickson, Royal Holloway University of London) with XbaI.</s><s>Two copies of the Spc5-12 sequence were inserted in tandem in a 5′ to 3′ orientation into pT2-hDYSF digested with SpeI (resulting vector -pT2-2xSpc5-12-hDYSF).</s><s>The IRES-GFP-poly(A) sequence was PCR-amplified from pT2-CAG-IRES-GFP with Pfu Ultra II Fusion DNA polymerase (Agilent Technologies, Santa Clara, CA) using the forward 5′-ATCTGCGGCCGCTAGCCAATTCC GCCCCTC-3′ and reverse 5′-TCTTGCGGCCGCTGTAC AACTAGTCGATCCCTCTTAAGTACCAC-3′ primers.</s><s>The resulting PCR fragment was digested with NotI and inserted into pT2-2xSpc5-12-hDYSF previously digested with NotI.</s></p><p><s>Cell culture.</s><s>Conditionally immortalized H2K and H2K A/J myoblasts <ref type="bibr" target="#b17">18</ref> were a gift from Terence Partridge, National Children's Hospital, Bethesda, MD.</s><s>Cells were cultured on dishes coated with 0.1% gelatin from porcine skin (Sigma-Aldrich, Saint Louis, MO).</s><s>H2K myoblasts were routinely tested for mycoplasma and experiments were only performed using mycoplasma-free cells.</s><s>To allow proliferation, H2K myoblasts were cultured at 33 °C and 10% CO 2 in Dulbecco's Modified Eagle Medium high glucose supplemented with GlutaMAX and pyruvate (Gibco, Life Technologies, Carlsbad, CA), 1× Antibiotic-Antimycotic (Gibco, Life Technologies), 20% fetal calf serum (PAA Laboratories, Pasching, Austria), 2% chick embryo extract (US Biological, Salem, MA), and 200 U/ml of γ-interferon (Merck Millipore, Darmstadt, Germany).</s><s>For differentiation, cells were placed into 37 °C and 5% CO 2 for 7 days in proliferation media devoid of γ-interferon and subsequently switched into Dulbecco's Modified Eagle Medium containing Antibiotic-Antimycotic, 5% horse serum (Gibco, Life Technologies), and 2% chick embryo extract.</s><s>Primary human myoblasts were isolated and purified as previously described. <ref type="bibr" target="#b52">53</ref></s><s>In brief, cells were grown in Skeletal Muscle Growth Medium (PromoCell, Heidelberg, Germany) supplemented with 10% fetal calf serum (Lonza, Basel, Switzerland), 2.72 mmol/l GlutaMAX, and 400 µg/ml gentamicin (Gibco, Life Technologies).</s><s>Differentiation into myotubes was induced in Dulbecco's Modified Eagle Medium containing 2% horse serum (Gibco, Life Technologies).</s></p><p><s>Transfection and sorting of H2K A/J myoblasts.</s><s>H2K A/J myoblasts were transfected with a Neon Transfection System (Life Technologies).</s><s>An electroporation protocol consisting of 1,050 mV, 30 ms, 2 pulses was selected due to an optimal ratio between transfection efficiency and cell viability.</s><s>Thoroughly washed cells were aliquoted according to the number of cells needed for each transfection.</s><s>Each aliquot was resuspended in buffer R (Neon Transfection System, Life Technologies) containing plasmid DNA and electroporated according to the manufacturer's instructions.</s><s>Immediately after electroporation, cells were plated in gelatin-coated dishes containing H2K myoblast proliferation media.</s><s>Routine flow cytometry to monitor expression of GFP was performed using a FACSCalibur flow cytometer (BD Biosciences, Franklin Lakes, NJ) and analysis of the flow cytometry data was performed with the Cellquest Pro (BD Biosciences) and FlowJo Softwares.</s><s>Sorting of GFP expressing H2K A/J myoblasts was done using a FACSAria flow cytometer (BD Biosciences).</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1</head><label>1</label><figDesc><div><p><s>Figure 1 Restoration of full-length dysferlin expression in H2K A/J muscle cells.</s><s>(a) Schematic view of the Sleeping Beauty (SB)based full-length, human dysferlin transfer vector (hDYSF-IRES-GFP).</s><s>Black arrows: transposon inverted terminal repeats.</s><s>(b) Enrichmentof the H2K A/J -DYSF + population.</s><s>hDYSF-IRES-GFP plus an expression vector for SB100X transposase were transfected into H2K A/J myoblasts and enriched by three rounds of FACS sorting, resulting in a 98.6% GFP + cell population.</s><s>(c) Immunoblot demonstrating dysferlin reconstitution in H2K A/J myoblasts (blue) and myotubes (black) (A/J-DYSF + GFP + ).</s><s>Note that dysferlin is expressed at a higher level in myotubes than in myoblasts.</s><s>No dysferlin is detected in H2K A/J cells that had not received the hDYSF-IRES-GFP-vector.</s><s>Additional controls were myoblasts and myotubes stably transfected with an SB-based vector encoding only a GFP reporter driven by the ubiquitous CAG promoter (pT2-CAG-IRES-GFP) and sorted for selecting the GFP-positive (A/J-GFP + ) and negative (A/J-GFP − ) populations.</s><s>Hu.myotubes, normal primary human myotubes.</s><s>Fast MyHC, fast myosin heavy chain.</s><s>(d) Immunostaining of dysferlin (red; Romeo ab) in H2K wt, H2K A/J, and H2K A/J-DYSF + myotubes.</s><s>Sarcolemmal dysferlin staining is shown in dysferlin-negative H2K A/J cells reconstituted with hDYSF-IRES-GFP.</s><s>Blue, DAPI.</s><s>Bars = 20 µm.</s><s>DAPI, 4',6-diamidino-2-phenylindole; IRES, Internal Ribosome Entry Site; PI, propidium iodide.</s></p></div></figDesc><graphic coords="3,99.59,83.10,393.74,286.34" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>-based gene therapy studies in dysferlin-deficient mouse models.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2</head><label>2</label><figDesc><div><p><s>Figure 2 Robust dysferlin reconstitution in skeletal muscle of Scid/BLA/J mice following transplantation of engineered myoblasts.</s><s>About 3 × 10 5 H2K A/J-DYSF + myoblasts were transplanted into the tibialis anterior (TA) muscles of Scid/BLA/J mice 1 day after local 18 Gy irradiation.</s><s>Representative images of cryosections from TA muscles collected 3 weeks (a) or 6 weeks (b) after transplantation and immunostained with an anti-dysferlin ab (red; Romeo ab).</s><s>Blue, Hoechst.</s><s>While donor-derived myofibers expressing dysferlin were present at low numbers (up to 140 fibers) in muscles that were only irradiated (a,b -left columns), they were very abundant (~500 to 1,100 after 3 weeks and ~400 (note that this number may be underestimated) to 1,000 after 6 weeks) and occupied large areas of grafted muscles (max.</s><s>area of 1,000 × 800 µm) that were subjected to a combined pretreatment of irradiation and CTX injection (a,b -middle and right columns).</s><s>Dysferlin was enriched at the membrane of the donor-derived myofibers (a,b -right columns).</s><s>Bars = 200 µm (left and middle columns)/50 µm (right columns).</s><s>CTX, cardiotoxin.</s></p></div></figDesc><graphic coords="4,149.89,90.24,318.86,403.94" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 3</head><label>3</label><figDesc><div><p><s>Figure 3 Donor-derived muscle shows histological features of regeneration.</s><s>Images of histological stains on cryosections from a grafted muscle collected 6 weeks after cell transplantation and injection of CTX.</s><s>(a) The area containing donor-derived myofibers is indicated in a cryosection from the same muscle immunostained with an anti-dysferlin ab (red; Romeo ab).</s><s>Bar = 200 µm.</s><s>(b) The delineation of the same area in a low magnification image of a Gomori Trichrome stain shows its large size and its clear demarcation from areas containing only host myofibers.</s><s>Bar = 500 µm.</s><s>(c-e) Donor-derived muscle shows hallmarks of regeneration, including higher fiber size variation, rounded myofibers, edematous interstitial space, basophilic fibers, and central nuclei as evidenced by the Hematoxylin and Eosin (c), NADHdehydrogenase (d), and Gomori Trichrome (e) stains.</s><s>Bars = 100 µm.</s><s>CTX, cardiotoxin.</s></p></div></figDesc><graphic coords="5,127.94,88.60,336.14,265.94" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 4</head><label>4</label><figDesc><div><p><s>Figure 4 Engineered myoblasts of donor origin gave rise to numerous Pax7 + cells in grafted muscles.</s><s>(a) Corresponding areas stained for dysferlin (red) and for laminin (green) in serial sections from a grafted muscle 6 weeks after transplantation of H2K A/J-DYSF + myoblasts.</s><s>The asterisks (*) and squares indicate the same areas in the left and right images.</s><s>The squares indicate the area shown in b.</s><s>Bars = 200 µm.</s><s>(b) Numerous Pax7 + (ochre) cells are present in areas containing donor-derived myofibers.</s><s>Some cells are located beneath forming basal lamina (green) structures and most of them are interstitial.</s><s>Blue, Hoechst.</s><s>Bar = 50 µm.</s><s>(c) Pax7 + cells (ochre) coexpress dysferlin (red; Romeo ab) and are located next to donor-derived myofibers.</s><s>Blue, Hoechst.</s><s>Bars = 10 µm.</s></p></div></figDesc><graphic coords="6,104.07,82.12,407.42,467.90" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc><div><p><s>When CTX was applied, 40 µl of 10 µmol/l CTX/PBS (Latoxan, Valence, France) was injected 1-2 minutes after the cells.At the indicated time points, mice were sacrificed.TA muscles were prepared and cut in two halves following a transversal plane.With the cutting edge atop, each half was separately mounted on cork plates and frozen in liquid nitrogen under cryoprotection.Frozen muscles were stored at −80 °C.Immunofluorescence staining of muscle sections.For dysferlin immunostaining, 6-µm transversal cryosections were air-dried for at least 30 minutes at RT and fixed for 5 minutes in acetone at −20 °C.After blocking, they were incubated overnight at 4 °C with the Romeo ab (1:100) in 1% bovine serum albumin/ PBS.Secondary anti-rabbit Cy3-conjugated ab was applied as above.Nuclei were counterstained with 4',6-diamidino-2-phenylindole (1:5,000).The sections were washed in PBS and ddH 2 O and mounted with Aqua Poly/Mount (Polysciences, Inc, Warrington, PA).For Pax7/laminin immunostaining, 6-µm cryosections were fixed in 4% paraformaldehyde, washed, and blocked with 5% bovine serum albumin, 3% donkey serum.After overnight incubation at 4 °C with a monoclonal mouse-anti-Pax7 ab (DSHB, Iowa City, IA, supernatant diluted 1:1 in sterile glycerol, working dilution 1:10) and rabbit polyclonal anti-laminin ab (Sigma-Aldrich L-9393, 1:200), sections were washed and incubated with secondary abs against mouse IgG (AlexaFluor 555, life technologies, 1:500) and rabbit IgG (AlexaFluor 647, life technologies, 1:500).Counterstain of nuclei, washing and mounting was performed as above.For Pax7/dysferlin immunostaining, 6-µm cryosections were fixed with 4% paraformaldehyde and blocked with 5% bovine serum albumin + 3% donkey serum.The sections were incubated overnight at 4 °C with mouse-anti-Pax7 ab (DSHB, stock as above, working dilution 1:5) and Romeo ab (1:50).Incubation with secondary antibodies against mouse and rabbit IgG as well as nuclei counterstaining and mounting were performed as above.H&amp;E, Gomori Trichrome, and NADH-dehydrogenase stainings were performed according to standard protocols.Image acquisition and processing.</s><s>All image-containing figures were built in Adobe Illustrator CS5 and image graphics were added in Adobe Illustrator CS5.</s><s>Images from immunofluorescence stainings on cultured cells and mouse muscle cryosections were acquired with a Zeiss LSM 700 confocal microscope and processed with Zen 2012 (Zeiss, Jena, Germany).</s><s>Dysferlin-positive fibers were counted with the cell counter plugin of ImageJ on confocal microscopy images of cryosections immunostained with the Romeo ab.</s><s>Images from histological stainings on mouse muscle cryosections were acquired with a Leica DM LB2 microscope (Leica Microsystems, Wetzlar, Germany) and processed with Adobe Photoshop CS5.</s><s>All modifications were always applied to the full image.</s></p></div></figDesc><table><row><cell>Sodium dodecyl sulfate-polyacrylamide gel electrophoresis</cell></row><row><cell>and immunoblot. For immunoblotting, myoblasts or myotubes</cell></row><row><cell>were lysed on ice with radioimmunoprecipitation assay buf-</cell></row><row><cell>fer (50 mmol/l Tris-HCl, 150 mmol/l NaCl, 0.1% NP-40, 0.1%</cell></row><row><cell>sodium dodecyl sulfate, 0.1% sodium deoxycholate, and</cell></row><row><cell>protease inhibitors). The protein concentration was deter-</cell></row><row><cell>mined using BCA Protein Assay Kit (Thermo Fisher Scien-</cell></row><row><cell>tific, Waltham, MA). For each sample, 10 µg protein diluted in</cell></row><row><cell>sample buffer (0.25 mol/l Tris-HCl, 50% glycerol, 5% sodium</cell></row><row><cell>dodecyl sulfate, 0.05% bromophenol blue, and 10% freshly</cell></row><row><cell>added β-mercaptoethanol) were loaded onto a Novex 8-16%</cell></row><row><cell>gradient Tris-glycine Mini Protein Gel (Life Technologies).</cell></row><row><cell>Proteins were separated in denaturing conditions and trans-</cell></row><row><cell>ferred to a polyvinylidene difluoride membrane using a wet</cell></row><row><cell>electroblotting system (Bio-Rad, Hercules, CA) in Tris-glycine</cell></row><row><cell>buffer containing 10% methanol and 0.02% sodium dodecyl</cell></row><row><cell>sulfate. Blocking was performed with 5% dry milk powder.</cell></row><row><cell>The membrane was then incubated with the primary antibod-</cell></row><row><cell>ies (ab) diluted in blocking buffer (anti-dysferlin, Novocastra</cell></row><row><cell>NCL-Hamlet, 1:500, overnight at 4 °C/anti-fast MyHC; Novo-</cell></row><row><cell>castra NCL-MHCf, 1:500, 1 hour at room temperature (RT)/</cell></row><row><cell>anti-alpha-tubulin; Sigma-Aldrich T6074, 1:2,000, 1 hour at</cell></row><row><cell>RT/anti-TurboGFP; Evrogen AB513, 1:5,000, overnight at</cell></row><row><cell>4 °C) followed by extensive washing. Incubation with the cor-</cell></row><row><cell>responding HRP-conjugated secondary abs was performed at</cell></row><row><cell>RT for 1 hour. After washing, the membrane was incubated with</cell></row><row><cell>ECL reagent (GE Healthcare, Milwaukee, WI) for 5 minutes and</cell></row><row><cell>imaged using a STELLA 3200 system (Raytest, Straubenhardt,</cell></row><row><cell>Germany). Images were processed using Adobe Photoshop</cell></row><row><cell>CS5. Any adaptations were applied to the full image with all</cell></row><row><cell>lanes only.</cell></row><row><cell>Dysferlin immunostaining in cultured myoblasts and myo-</cell></row><row><cell>tubes. For immunofluorescence staining, H2K myoblasts in</cell></row><row><cell>ibidi wells (80826 ibidi, Planegg, Germany) were fixed for</cell></row><row><cell>5 minutes in methanol at −20 °C, washed with phosphate-</cell></row><row><cell>buffered saline (PBS), and blocked with 1% bovine serum</cell></row><row><cell>albumin/PBS for 1 hour at RT. Dysferlin was detected using</cell></row><row><cell>the Romeo ab specific to the N-terminal part of dysferlin</cell></row><row><cell>(Abcam ab124684, 1:200, Cambridge, UK). After washing, a</cell></row><row><cell>Cy3-conjugated secondary anti-rabbit ab was added (Jack-</cell></row><row><cell>son ImmunoResearch 711-165-152, 1:500, West Grove, PA).</cell></row><row><cell>Nuclei were counterstained with 4',6-diamidino-2-phenylin-</cell></row><row><cell>dole (1:10,000 in PBS). The wells were washed, sealed, and</cell></row><row><cell>kept at 4 °C until imaging.</cell></row><row><cell>Mouse experiments. B6.Cg-Dysf prmd Prkdc scid /J (Scid/BLA/J)</cell></row><row><cell>homozygous for the Dysf prmd and Prkdc scid alleles were pur-</cell></row><row><cell>chased from The Jackson Laboratory and bred in our specific</cell></row><row><cell>pathogen-free animal facility. All animal experiments were per-</cell></row><row><cell>formed under the license number G0035/14 (LaGeSo, Berlin,</cell></row><row><cell>Germany). Focal irradiation of mouse hind limbs was performed</cell></row><row><cell>as described. Supplementary</cell></row></table><note><p><s>27For transplantation, cultured H2K myoblasts were washed and resuspended in Dulbecco's Modified Eagle Medium containing 2% fetal calf serum.Eight 12-15-week-old female Scid/BLA/J mice were anesthetized with ketamine-xylazine (9 mg/ml ketamine, 1.2 mg/ml xylazine) in sterile PBS at a dose of 160 µl/20 g.The area above the TA was shaved and disinfected and 30 µl of cell suspension were injected with a 26-gauge hypodermic needle in the median portion of the TA.material FigureS1.</s><s>SB transposition in H2K A/J myoblasts.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Human Full-length Dysferlin for Gene Therapy Escobar et al.</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">www.moleculartherapy.org/mtnaHuman Full-length Dysferlin for Gene Therapy Escobar et al.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>The work was supported by the German Research Society (DFG) through GK1631 "MyoGrad" and KFO192 (Sp1152/8-1).</s><s>There is no conflict of interest.</s><s>H.E. performed all experiments.</s><s>V.S. helped with the animal experi-ments.</s><s>S.S. designed the study, discussed data, and wrote the manuscript.</s><s>A.M. performed immunofluorescence, designed experiments, and discussed data.</s><s>Z.I. supervised and discussed the experiments using the Sleeping Beauty based vector.</s><s>Z.I was supported by ERC-2011-AdG 294742.</s><s>H.E. was supported by GK1631 and by the Association française contre les myopathies (AFM-Téléthon).</s><s>The authors thank Terence Partridge for providing H2K and H2K A/J cells and Adrienne Rothe and Kornelia Gräning for excellent technical assistance.</s></p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy</title>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Aoki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Illa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fardeau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Angelini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="31" to="36" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B</title>
		<author>
			<persName><forename type="first">R</forename><surname>Bashir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Britton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Strachan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Keers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vafiadaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lako</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="37" to="42" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype</title>
		<author>
			<persName><forename type="first">I</forename><surname>Illa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Serrano-Munuera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gallardo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lasa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rojas-García</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Palmer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="130" to="134" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy</title>
		<author>
			<persName><forename type="first">M</forename><surname>Aoki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Richard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bashir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Britton</surname></persName>
		</author>
		<author>
			<persName><surname>Keers</surname></persName>
		</author>
		<author>
			<persName><surname>Sm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="271" to="278" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Ferlins: regulators of vesicle fusion for auditory neurotransmission, receptor trafficking and membrane repair</title>
		<author>
			<persName><forename type="first">A</forename><surname>Lek</surname></persName>
		</author>
		<author>
			<persName><surname>Evesson</surname></persName>
		</author>
		<author>
			<persName><surname>Fj</surname></persName>
		</author>
		<author>
			<persName><surname>Sutton</surname></persName>
		</author>
		<author>
			<persName><surname>Rb</surname></persName>
		</author>
		<author>
			<persName><surname>North</surname></persName>
		</author>
		<author>
			<persName><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><surname>St</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Traffic</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="185" to="194" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Dysferlin is a plasma membrane protein and is expressed early in human development</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">V</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Davison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Moss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><surname>Cullen</surname></persName>
		</author>
		<author>
			<persName><surname>Mj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Walsh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="855" to="861" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">In vivo and in vitro dysferlin expression in human muscle satellite cells</title>
		<author>
			<persName><forename type="first">De</forename><surname>Luna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Gallardo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Illa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="1104" to="1113" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Intracellular localization of dysferlin and its association with the dihydropyridine receptor</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Ampong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Imamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Matsumiya</surname></persName>
		</author>
		<author>
			<persName><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Takeda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Myol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="134" to="144" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Dysferlin stabilizes stress-induced Ca 2+ signaling in the transverse tubule membrane</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Kerr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Ziman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Mueller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Muriel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kleinhans-Welte</surname></persName>
		</author>
		<author>
			<persName><surname>Gumerson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="20831" to="20836" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Defective membrane repair in dysferlin-deficient muscular dystrophy</title>
		<author>
			<persName><forename type="first">D</forename><surname>Bansal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miyake</surname></persName>
		</author>
		<author>
			<persName><surname>Vogel</surname></persName>
		</author>
		<author>
			<persName><surname>Ss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Groh</surname></persName>
		</author>
		<author>
			<persName><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><surname>Cc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Williamson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">423</biblScope>
			<biblScope unit="page" from="168" to="172" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Increased susceptibility to complement attack due to down-regulation of decay-accelerating factor/ CD55 in dysferlin-deficient muscular dystrophy</title>
		<author>
			<persName><forename type="first">K</forename><surname>Wenzel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zabojszcza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Carl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Taubert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lass</surname></persName>
		</author>
		<author>
			<persName><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><surname>Cl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">175</biblScope>
			<biblScope unit="page" from="6219" to="6225" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice</title>
		<author>
			<persName><forename type="first">R</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Frett</surname></persName>
		</author>
		<author>
			<persName><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><surname>Rader</surname></persName>
		</author>
		<author>
			<persName><surname>Ep</surname></persName>
		</author>
		<author>
			<persName><surname>Lueck</surname></persName>
		</author>
		<author>
			<persName><surname>Jd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bansal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="4366" to="4374" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">The Sleeping Beauty transposon system for clinical applications</title>
		<author>
			<persName><forename type="first">M</forename><surname>Swierczek</surname></persName>
		</author>
		<author>
			<persName><surname>Izsvák</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Ivics</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Expert Opin Biol Ther</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="139" to="153" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Izsvák</surname></persName>
		</author>
		<author>
			<persName><surname>Ivics</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Plasterk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Biol</title>
		<imprint>
			<biblScope unit="volume">302</biblScope>
			<biblScope unit="page" from="93" to="102" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates</title>
		<author>
			<persName><forename type="first">L</forename><surname>Mátés</surname></persName>
		</author>
		<author>
			<persName><surname>Chuah</surname></persName>
		</author>
		<author>
			<persName><surname>Mk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Belay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Jerchow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Manoj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Acosta-Sanchez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="753" to="761" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Transposonmediated BAC transgenesis in human ES cells</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rostovskaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Obst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Baer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Weidlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page">e150</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignancies</title>
		<author>
			<persName><forename type="first">P</forename><surname>Kebriaei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Huls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jena</forename></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Munsell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><surname>Da</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Gene Ther</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="444" to="450" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Myogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory response</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">V</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Partridge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuromuscul Disord</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="648" to="658" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Beauchamp</surname></persName>
		</author>
		<author>
			<persName><surname>Pagel</surname></persName>
		</author>
		<author>
			<persName><surname>Cn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Peckham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ataliotis</surname></persName>
		</author>
		<author>
			<persName><surname>Jat</surname></persName>
		</author>
		<author>
			<persName><surname>Ps</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dev Biol</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="page" from="486" to="498" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><surname>Post</surname></persName>
		</author>
		<author>
			<persName><surname>Cm</surname></persName>
		</author>
		<author>
			<persName><surname>Donahue</surname></persName>
		</author>
		<author>
			<persName><surname>Lr</surname></persName>
		</author>
		<author>
			<persName><surname>Lidov</surname></persName>
		</author>
		<author>
			<persName><surname>Hg</surname></persName>
		</author>
		<author>
			<persName><surname>Bronson</surname></persName>
		</author>
		<author>
			<persName><surname>Rt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Goolsby</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="1999" to="2010" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Jat</surname></persName>
		</author>
		<author>
			<persName><surname>Noble</surname></persName>
		</author>
		<author>
			<persName><surname>Md</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ataliotis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Yannoutsos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Larsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="5096" to="5100" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model</title>
		<author>
			<persName><forename type="first">A</forename><surname>Farini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sitzia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Navarro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>'antona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Belicchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Parolini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Cell Res</title>
		<imprint>
			<biblScope unit="volume">318</biblScope>
			<biblScope unit="page" from="1160" to="1174" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences</title>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Eastman</surname></persName>
		</author>
		<author>
			<persName><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Draghia-Akli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Biotechnol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="241" to="245" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2/8 gene transfer</title>
		<author>
			<persName><forename type="first">H</forename><surname>Foster</surname></persName>
		</author>
		<author>
			<persName><surname>Sharp</surname></persName>
		</author>
		<author>
			<persName><surname>Ps</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Athanasopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Trollet</surname></persName>
		</author>
		<author>
			<persName><surname>Graham</surname></persName>
		</author>
		<author>
			<persName><surname>Ir</surname></persName>
		</author>
		<author>
			<persName><surname>Foster</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Ther</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="1825" to="1832" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx mice</title>
		<author>
			<persName><forename type="first">T</forename><surname>Koo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Malerba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Athanasopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Trollet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Boldrin</surname></persName>
		</author>
		<author>
			<persName><surname>Ferry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Gene Ther</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1379" to="1388" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Donor satellite cell engraftment is significantly augmented when the host niche is preserved and endogenous satellite cells are incapacitated</title>
		<author>
			<persName><forename type="first">L</forename><surname>Boldrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Neal</surname></persName>
		</author>
		<author>
			<persName><surname>Zammit</surname></persName>
		</author>
		<author>
			<persName><surname>Ps</surname></persName>
		</author>
		<author>
			<persName><surname>Muntoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Morgan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stem Cells</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="1971" to="1984" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Human satellite cells have regenerative capacity and are genetically manipulable</title>
		<author>
			<persName><forename type="first">A</forename><surname>Marg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Escobar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gloy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kufeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zacher</surname></persName>
		</author>
		<author>
			<persName><surname>Spuler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="4257" to="4265" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Recent progress in satellite cell/myoblast engraftment -relevance for therapy</title>
		<author>
			<persName><surname>Briggs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Morgan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS J</title>
		<imprint>
			<biblScope unit="volume">280</biblScope>
			<biblScope unit="page" from="4281" to="4293" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Changes in motor end-plates resulting from muscle fibre necrosis and regeneration. A light and electron microscopic study of the effects of the depolarizing fraction (cardiotoxin) of Dendroaspis jamesoni venom</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Duchen</surname></persName>
		</author>
		<author>
			<persName><surname>Excell</surname></persName>
		</author>
		<author>
			<persName><surname>Bj</surname></persName>
		</author>
		<author>
			<persName><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><surname>Smith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="391" to="417" />
			<date type="published" when="1974">1974</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Pax7 is required for the specification of myogenic satellite cells</title>
		<author>
			<persName><forename type="first">P</forename><surname>Seale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Sabourin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Girgis-Gabardo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mansouri</surname></persName>
		</author>
		<author>
			<persName><surname>Gruss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Rudnicki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="777" to="786" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Satellite cell of skeletal muscle fibers</title>
		<author>
			<persName><forename type="first">A</forename><surname>Mauro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biophys Biochem Cytol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="493" to="495" />
			<date type="published" when="1961">1961</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice</title>
		<author>
			<persName><forename type="first">K</forename><surname>Leriche-Guérin</surname></persName>
		</author>
		<author>
			<persName><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><surname>Lv</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wrogemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Roy</surname></persName>
		</author>
		<author>
			<persName><surname>Goulet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Tremblay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuromuscul Disord</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="167" to="173" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Homologous recombination mediates functional recovery of dysferlin deficiency following AAV5 gene transfer</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Grose</surname></persName>
		</author>
		<author>
			<persName><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><surname>Kr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Griffin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Malik</surname></persName>
		</author>
		<author>
			<persName><surname>Shontz</surname></persName>
		</author>
		<author>
			<persName><surname>Km</surname></persName>
		</author>
		<author>
			<persName><surname>Montgomery</surname></persName>
		</author>
		<author>
			<persName><surname>Cl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e39233</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">AAV.Dysferlin overlap vectors restore function in dysferlinopathy animal models</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Sondergaard</surname></persName>
		</author>
		<author>
			<persName><surname>Griffin</surname></persName>
		</author>
		<author>
			<persName><surname>Da</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Pozsgai</surname></persName>
		</author>
		<author>
			<persName><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><surname>Rw</surname></persName>
		</author>
		<author>
			<persName><surname>Grose</surname></persName>
		</author>
		<author>
			<persName><surname>We</surname></persName>
		</author>
		<author>
			<persName><surname>Heller</surname></persName>
		</author>
		<author>
			<persName><surname>Kn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Clin Transl Neurol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="256" to="270" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer</title>
		<author>
			<persName><forename type="first">W</forename><surname>Lostal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bartoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bourg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Roudaut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bentaïb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miyake</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1897" to="1907" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">The potential of adeno-associated viral vectors for gene delivery to muscle tissue</title>
		<author>
			<persName><forename type="first">D</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">,</forename><surname>Nahid</surname></persName>
		</author>
		<author>
			<persName><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Expert Opin Drug Deliv</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="345" to="364" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133 + stem cells</title>
		<author>
			<persName><forename type="first">M</forename><surname>Meregalli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Navarro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sitzia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Farini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Montani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Wein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS J</title>
		<imprint>
			<biblScope unit="volume">280</biblScope>
			<biblScope unit="page" from="6045" to="6060" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Lariat branch point mutation in the dysferlin gene with mild limb-girdle muscular dystrophy</title>
		<author>
			<persName><forename type="first">M</forename><surname>Sinnreich</surname></persName>
		</author>
		<author>
			<persName><surname>Therrien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Karpati</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="1114" to="1116" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Efficient bypass of mutations in dysferlin deficient patient cells by antisense-induced exon skipping</title>
		<author>
			<persName><forename type="first">N</forename><surname>Wein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Avril</forename></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bartoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Beley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chaouch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Laforêt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mutat</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="136" to="142" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Dysferlin rescue by spliceosome-mediated pre-mRNA trans-splicing targeting introns harbouring weakly defined 3&apos; splice sites</title>
		<author>
			<persName><forename type="first">S</forename><surname>Philippi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lorain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Beley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Peccate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Précigout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Spuler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="4049" to="4060" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">A novel dysferlin mutant pseudoexon bypassed with antisense oligonucleotides</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Dominov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Uyan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Sapp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mckenna-Yasek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">,</forename><surname>Nallamilli</surname></persName>
		</author>
		<author>
			<persName><surname>Br</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hegde</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Clin Transl Neurol</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="703" to="720" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><surname>Gross</surname></persName>
		</author>
		<author>
			<persName><surname>Jg</surname></persName>
		</author>
		<author>
			<persName><surname>Pagel</surname></persName>
		</author>
		<author>
			<persName><surname>Cn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Beauchamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fassati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Thrasher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Biol</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="page" from="693" to="702" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">The effect of the muscle environment on the regenerative capacity of human skeletal muscle stem cells</title>
		<author>
			<persName><forename type="first">J</forename><surname>Meng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bencze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Asfahani</surname></persName>
		</author>
		<author>
			<persName><surname>Muntoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Morgan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Skelet Muscle</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">11</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration</title>
		<author>
			<persName><forename type="first">R</forename><surname>Sambasivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kissenpfennig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Van</forename><surname>Wittenberghe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Paldi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gayraud-Morel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Development</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page" from="3647" to="3656" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lepper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">,</forename><surname>Partridge</surname></persName>
		</author>
		<author>
			<persName><surname>Ta</surname></persName>
		</author>
		<author>
			<persName><surname>Fan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Development</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page" from="3639" to="3646" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy</title>
		<author>
			<persName><forename type="first">J</forename><surname>Díaz-Manera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Touvier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dellavalle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tonlorenzi</surname></persName>
		</author>
		<author>
			<persName><surname>Tedesco</surname></persName>
		</author>
		<author>
			<persName><surname>Fs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Messina</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Death Dis</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page">e61</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Intramuscular transplantation of human postnatal myoblasts generates functional donorderived satellite cells</title>
		<author>
			<persName><forename type="first">D</forename><surname>Skuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Paradis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Goulet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chapdelaine</surname></persName>
		</author>
		<author>
			<persName><surname>Rothstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Tremblay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Ther</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1689" to="1697" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding</title>
		<author>
			<persName><forename type="first">K</forename><surname>Wenzel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Carl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Perrot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zabojszcza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Assadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ebeling</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mutat</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="599" to="600" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Dysferlin overexpression in skeletal muscle produces a progressive myopathy</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Glover</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Newton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Krishnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bronson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Boyle</surname></persName>
		</author>
		<author>
			<persName><surname>Krivickas</surname></persName>
		</author>
		<author>
			<persName><surname>Ls</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="384" to="393" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Gene transfer efficiency and genome-wide integration profiling of Sleeping Beauty, Tol2, and piggyBac transposons in human primary T cells</title>
		<author>
			<persName><forename type="first">X</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tammana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Mellgren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bassi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Ther</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1803" to="1813" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Comparative genomic integration profiling of Sleeping Beauty transposons mobilized with high efficacy from integrase-defective lentiviral vectors in primary human cells</title>
		<author>
			<persName><forename type="first">B</forename><surname>Moldt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Miskey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">H</forename><surname>Staunstrup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gogol-Döring</surname></persName>
		</author>
		<author>
			<persName><surname>Bak</surname></persName>
		</author>
		<author>
			<persName><surname>Ro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sharma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Ther</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1499" to="1510" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Sleeping Beauty transposon-based system for cellular reprogramming and targeted gene insertion in induced pluripotent stem cells</title>
		<author>
			<persName><forename type="first">I</forename><surname>Grabundzija</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sebe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Erdei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kajdi</surname></persName>
		</author>
		<author>
			<persName><surname>Devaraj</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="1829" to="1847" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">V</forename><surname>Schoewel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Marg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kunz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Overkamp</surname></persName>
		</author>
		<author>
			<persName><surname>Carrazedo</surname></persName>
		</author>
		<author>
			<persName><surname>Rs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Zacharias</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Dysferlin-peptides reallocate mutated dysferlin thereby restoring function</title>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e49603</biblScope>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
